Cyberonics Inc (CYBX)

CYBX (NASDAQ:Health Services)
$52.03
pos +0.33
+0.64%
Today's Range: 51.46 - 52.09 | CYBX Avg Daily Volume: 299,700
Last Update: 10/22/14 - 11:25 AM EDT
Volume: 22,611
YTD Performance: -21.45%
Open: $51.97
Previous Close: $51.70
52 Week Range: $49.23 - $73.52
Oustanding Shares: 26,624,906
Market Cap: 1,368,253,919
6-Month Chart
TheStreet Ratings Grade for CYBX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 7 7
Moderate Buy 0 0 0 0
Hold 2 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.50 1.50 1.25 1.25
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.47
Price Earnings Comparisons:
CYBX Sector Avg. S&P 500
23.47 23.50 27.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-10.55% -9.14% 90.69%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 0.48 0.14
Net Income 18.40 0.17 0.05
EPS 20.70 0.21 0.06
Earnings for CYBX:
EBITDA 0.09B
Revenue 0.28B
Average Earnings Estimates
Qtr (10/14) Qtr (01/15) FY (04/15) FY (04/16)
Average Estimate $0.59 $0.57 $2.35 $2.76
Number of Analysts 5 5 6 5
High Estimate $0.61 $0.60 $2.36 $2.82
Low Estimate $0.57 $0.54 $2.33 $2.70
Prior Year $0.50 $0.51 $2.04 $2.35
Growth Rate (Year over Year) 18.00% 11.37% 15.03% 17.70%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bearishCyberonics downgraded at Canaccord

Aug 22, 2014 | 7:12 AM EDT

CYBX was downgraded from Buy to Hold, Canaccord Genuity said. $52 price target. New U.S. patient growth is slowing. 

bullishCyberonics price target and estimates raised at Lazard

Jun 6, 2013 | 8:34 AM EDT

CYBX earnings estimates were increased on raised guidance as strength is seen across the U.S. and Europe, Lazard Capital. Price target increased to $57.

bullishCyberonics upgraded at Lazard

Mar 4, 2013 | 7:22 AM EST

CYBX was upgraded to Buy, Lazard Capital Market said. A proprietary survey showed that sales reps were not using inappropriate sales tactics, making the recent pullback a buying opportunity. Estimates through 2014 were raised, $57 price target. 

bullishCyberonics numbers raised at Canaccord

Nov 19, 2012 | 8:43 AM EST

Shares of CYBX now seen reaching $57, Canaccord said. Estimates also raised on a record quarter. Buy rating.

bullishCyberonics upgraded at Canaccord

Aug 29, 2012 | 6:35 AM EDT

CYBX was upgraded from Hold to Buy, Canaccord Genuity said. $56 price target. Company continues to execute well and depression treatment should drive near-term growth. 

By

Timothy Collins

 | Aug 27, 2012 | 3:19 PM EDT

I’m making trades in Movado and Sanderson Farms but passing on Cyberonics and PVH.

By

Timothy Collins

 | Aug 27, 2012 | 11:34 AM EDT

There are four reports coming up I find interesting.

By

Ken Shreve

 | Aug 26, 2012 | 6:00 PM EDT

Contributor Ken Shreve takes a look at upcoming economic data and some key earnings reports for the week of Aug. 27

By

Kate Stalter

 | Aug 3, 2012 | 1:00 PM EDT

These promising medical-device names aren’t on the S&P, but they deserve plenty of attention.

bullishCyberonics numbers raised at Jefferies

Jul 16, 2012 | 8:13 AM EDT

Shares of CYBX now seen reaching $58, Jefferies said. Estimates also raised on Chance of reversing coverage policy. Buy rating.

HON has had a powerful recovery off last Wednesday's spike low. After taking an ugly...
Recent spin-off Knowles Corp (KN) has been blasted since pre-announcing a bad quarter whic...

On October 13th, I suggested it was time to buy iRobot (IRBT)...

For those involved in the long FCG trade discussed here in CC, and in the Trader Daily, I ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.